Akèy › Kansè rektal › Washington › Seattle
Etid klinik pou Kansè rektal nan Seattle, WA
9 etid pou Kansè rektal ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Ap rekriteVolontè an sante akeyi
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi lwen
Family Communications After Genetic Testing
Ap rekriteVolontè an sante akeyi
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- ak 1 plis
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Ap rekriteFaz 3
- Fred Hutchinson Cancer Center ( Site 0076), Seattle
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
Ap rekriteEtid obsèvasyon
- Fred Hutch, Seattle
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Ap rekrite
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi lwen
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Ap rekriteFaz 3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
- Fred Hutch Cancer Center, Seattle
Etid Kansè rektal nan lòt vil
- New York City, NY17 etid
- Boston, MA12 etid
- Houston, TX11 etid
- St. Louis, MO11 etid
- Columbus, OH10 etid
- Los Angeles, CA10 etid
- Tampa, FL9 etid
- Nashville, TN9 etid
- Rochester, MN8 etid
- Chicago, IL8 etid
- Edison, NJ8 etid
- Salt Lake City, UT8 etid
Lòt etid nan Seattle
- Kansè Poumon ki pa ti selil53 etid
- Kansè (tout kalite)49 etid
- Kansè pwostat42 etid
- Leksemi mieloïd egi40 etid
- Kansè nan tete39 etid
- Kansè Metastatik39 etid
- Kansè kolorektal34 etid
- Kansè poumon33 etid
- Kansè ovè30 etid
- Myelom Miltip22 etid
- Sendwòm myelodisplastik21 etid
- Leksemi limfoblastik egi21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.